By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy
- Home
- Pharmaceuticals
- Report Detail
Global Etanercept Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Etanercept manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Etanercept market. Further, it explains the major drivers and regional dynamics of the global Etanercept market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
- Amgen
- Pfizer
- Takeda
- Sanofi
- GlaxoSmithKline
- Sandoz
- Celltrion
- Dexa Medica
- Bionovis
- Momenta Pharmaceuticals
- HanAll Biopharma
- MedImmune
- Tsumura
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Etanercept Segment by Type
- Benepali
- Enbrel
- Others
Etanercept Segment by Application
- Arthritis
- Psoriasis
- Spondylitis
- Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Etanercept market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Etanercept, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Etanercept, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Etanercept, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Etanercept sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Etanercept market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Etanercept sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Amgen, Pfizer, Takeda, Sanofi, GlaxoSmithKline, Sandoz, Celltrion, Dexa Medica and Bionovis, etc.
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Etanercept Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Benepali
1.2.3 Enbrel
1.2.4 Others
1.3 Market Segment by Application
1.3.1 Global Etanercept Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Arthritis
1.3.3 Psoriasis
1.3.4 Spondylitis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Etanercept Market Size (2017-2028)
2.1.1 Global Etanercept Revenue (2017-2028)
2.1.2 Global Etanercept Sales (2017-2028)
2.2 Global Etanercept Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Etanercept Sales by Regions (2017-2022)
2.2.2 Global Etanercept Revenue by Regions (2017-2022)
2.3 Global Etanercept Market Size Forecast by Region
2.3.1 Global Etanercept Sales Forecast by Region (2023-2028)
2.3.2 Global Etanercept Revenue Forecast by Region (2023-2028)
2.4 Global Top Etanercept Regions (Countries) Ranking by Market Size
2.5 Etanercept Market Dynamics
2.5.1 Etanercept Market Trends
2.5.2 Etanercept Market Drivers
2.5.3 Etanercept Market Challenges
2.5.4 Etanercept Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Etanercept Manufacturers by Sales (2017-2022)
3.1.1 Global Etanercept Sales by Manufacturers (2017-2022)
3.1.2 Global Etanercept Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Etanercept Sales in 2021
3.2 Global Top Manufacturers Etanercept by Revenue
3.2.1 Global Etanercept Revenue by Manufacturers (2017-2022)
3.2.2 Top Etanercept Manufacturers Covered: Ranking by Revenue
3.2.3 Global Etanercept Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Etanercept Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Etanercept as of 2021)
3.4 Global Etanercept Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Etanercept Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Etanercept Market
3.7 Key Manufacturers Etanercept Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Etanercept Market Size by Type
4.1 Global Etanercept Historic Market Review by Type (2017-2022)
4.1.1 Global Etanercept Sales Market Share by Type (2017-2022)
4.1.2 Global Etanercept Revenue Market Share by Type (2017-2022)
4.1.3 Etanercept Price by Type (2017-2022)
4.2 Global Etanercept Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Etanercept Sales Forecast by Type (2023-2028)
4.2.2 Global Etanercept Revenue Forecast by Type (2023-2028)
4.2.3 Etanercept Price Forecast by Type (2023-2028)
5 Global Etanercept Market Size by Application
5.1 Global Etanercept Historic Market Review by Application (2017-2022)
5.1.1 Global Etanercept Sales Market Share by Application (2017-2022)
5.1.2 Global Etanercept Revenue Market Share by Application (2017-2022)
5.1.3 Etanercept Price by Application (2017-2022)
5.2 Global Etanercept Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Etanercept Sales Forecast by Application (2023-2028)
5.2.2 Global Etanercept Revenue Forecast by Application (2023-2028)
5.2.3 Etanercept Price Forecast by Application (2023-2028)
6 North America
6.1 North America Etanercept Sales Breakdown by Company
6.1.1 North America Etanercept Sales by Company (2017-2022)
6.1.2 North America Etanercept Revenue by Company (2017-2022)
6.2 North America Etanercept Market Size by Type
6.2.1 North America Etanercept Sales by Type (2017-2028)
6.2.2 North America Etanercept Revenue by Type (2017-2028)
6.3 North America Etanercept Market Size by Application
6.3.1 North America Etanercept Sales by Application (2017-2028)
6.3.2 North America Etanercept Revenue by Application (2017-2028)
6.4 North America Etanercept Market Size by Country
6.4.1 North America Etanercept Sales by Country (2017-2028)
6.4.2 North America Etanercept Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Etanercept Sales Breakdown by Company
7.1.1 Europe Etanercept Sales by Company (2017-2022)
7.1.2 Europe Etanercept Revenue by Company (2017-2022)
7.2 Europe Etanercept Market Size by Type
7.2.1 Europe Etanercept Sales by Type (2017-2028)
7.2.2 Europe Etanercept Revenue by Type (2017-2028)
7.3 Europe Etanercept Market Size by Application
7.3.1 Europe Etanercept Sales by Application (2017-2028)
7.3.2 Europe Etanercept Revenue by Application (2017-2028)
7.4 Europe Etanercept Market Size by Country
7.4.1 Europe Etanercept Sales by Country (2017-2028)
7.4.2 Europe Etanercept Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Etanercept Sales Breakdown by Company
8.1.1 Asia Pacific Etanercept Sales by Company (2017-2022)
8.1.2 Asia Pacific Etanercept Revenue by Company (2017-2022)
8.2 Asia Pacific Etanercept Market Size by Type
8.2.1 Asia Pacific Etanercept Sales by Type (2017-2028)
8.2.2 Asia Pacific Etanercept Revenue by Type (2017-2028)
8.3 Asia Pacific Etanercept Market Size by Application
8.3.1 Asia Pacific Etanercept Sales by Application (2017-2028)
8.3.2 Asia Pacific Etanercept Revenue by Application (2017-2028)
8.4 Asia Pacific Etanercept Market Size by Region
8.4.1 Asia Pacific Etanercept Sales by Region
8.4.2 Asia Pacific Etanercept Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Etanercept Sales Breakdown by Company
9.1.1 Latin America Etanercept Sales by Company (2017-2022)
9.1.2 Latin America Etanercept Revenue by Company (2017-2022)
9.2 Latin America Etanercept Market Size by Type
9.2.1 Latin America Etanercept Sales by Type (2017-2028)
9.2.2 Latin America Etanercept Revenue by Type (2017-2028)
9.3 Latin America Etanercept Market Size by Application
9.3.1 Latin America Etanercept Sales by Application (2017-2028)
9.3.2 Latin America Etanercept Revenue by Application (2017-2028)
9.4 Latin America Etanercept Market Size by Country
9.4.1 Latin America Etanercept Sales by Country (2017-2028)
9.4.2 Latin America Etanercept Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Etanercept Sales Breakdown by Company
10.1.1 Middle East and Africa Etanercept Sales by Company (2017-2022)
10.1.2 Middle East and Africa Etanercept Revenue by Company (2017-2022)
10.2 Middle East and Africa Etanercept Market Size by Type
10.2.1 Middle East and Africa Etanercept Sales by Type (2017-2028)
10.2.2 Middle East and Africa Etanercept Revenue by Type (2017-2028)
10.3 Middle East and Africa Etanercept Market Size by Application
10.3.1 Middle East and Africa Etanercept Sales by Application (2017-2028)
10.3.2 Middle East and Africa Etanercept Revenue by Application (2017-2028)
10.4 Middle East and Africa Etanercept Market Size by Country
10.4.1 Middle East and Africa Etanercept Sales by Country (2017-2028)
10.4.2 Middle East and Africa Etanercept Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Overview
11.1.3 Amgen Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Amgen Etanercept Products and Services
11.1.5 Amgen Etanercept SWOT Analysis
11.1.6 Amgen Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Pfizer Etanercept Products and Services
11.2.5 Pfizer Etanercept SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Overview
11.3.3 Takeda Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Takeda Etanercept Products and Services
11.3.5 Takeda Etanercept SWOT Analysis
11.3.6 Takeda Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Sanofi Etanercept Products and Services
11.4.5 Sanofi Etanercept SWOT Analysis
11.4.6 Sanofi Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Etanercept Products and Services
11.5.5 GlaxoSmithKline Etanercept SWOT Analysis
11.5.6 GlaxoSmithKline Recent Developments
11.6 Sandoz
11.6.1 Sandoz Corporation Information
11.6.2 Sandoz Overview
11.6.3 Sandoz Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Sandoz Etanercept Products and Services
11.6.5 Sandoz Etanercept SWOT Analysis
11.6.6 Sandoz Recent Developments
11.7 Celltrion
11.7.1 Celltrion Corporation Information
11.7.2 Celltrion Overview
11.7.3 Celltrion Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Celltrion Etanercept Products and Services
11.7.5 Celltrion Etanercept SWOT Analysis
11.7.6 Celltrion Recent Developments
11.8 Dexa Medica
11.8.1 Dexa Medica Corporation Information
11.8.2 Dexa Medica Overview
11.8.3 Dexa Medica Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Dexa Medica Etanercept Products and Services
11.8.5 Dexa Medica Etanercept SWOT Analysis
11.8.6 Dexa Medica Recent Developments
11.9 Bionovis
11.9.1 Bionovis Corporation Information
11.9.2 Bionovis Overview
11.9.3 Bionovis Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Bionovis Etanercept Products and Services
11.9.5 Bionovis Etanercept SWOT Analysis
11.9.6 Bionovis Recent Developments
11.10 Momenta Pharmaceuticals
11.10.1 Momenta Pharmaceuticals Corporation Information
11.10.2 Momenta Pharmaceuticals Overview
11.10.3 Momenta Pharmaceuticals Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Momenta Pharmaceuticals Etanercept Products and Services
11.10.5 Momenta Pharmaceuticals Etanercept SWOT Analysis
11.10.6 Momenta Pharmaceuticals Recent Developments
11.11 HanAll Biopharma
11.11.1 HanAll Biopharma Corporation Information
11.11.2 HanAll Biopharma Overview
11.11.3 HanAll Biopharma Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 HanAll Biopharma Etanercept Products and Services
11.11.5 HanAll Biopharma Recent Developments
11.12 MedImmune
11.12.1 MedImmune Corporation Information
11.12.2 MedImmune Overview
11.12.3 MedImmune Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 MedImmune Etanercept Products and Services
11.12.5 MedImmune Recent Developments
11.13 Tsumura
11.13.1 Tsumura Corporation Information
11.13.2 Tsumura Overview
11.13.3 Tsumura Etanercept Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 Tsumura Etanercept Products and Services
11.13.5 Tsumura Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Etanercept Value Chain Analysis
12.2 Etanercept Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Etanercept Production Mode & Process
12.4 Etanercept Sales and Marketing
12.4.1 Etanercept Sales Channels
12.4.2 Etanercept Distributors
12.5 Etanercept Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Etanercept Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Benepali
Table 3. Major Manufacturers of Enbrel
Table 4. Major Manufacturers of Others
Table 5. Global Etanercept Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Etanercept Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Etanercept Sales by Region (2017-2022) & (K Units)
Table 8. Global Etanercept Sales Market Share by Region (2017-2022)
Table 9. Global Etanercept Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Etanercept Revenue Market Share by Region (2017-2022)
Table 11. Global Etanercept Sales Forecast by Region (2023-2028) & (K Units)
Table 12. Global Etanercept Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Etanercept Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Etanercept Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Etanercept Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Etanercept Market Trends
Table 17. Etanercept Market Drivers
Table 18. Etanercept Market Challenges
Table 19. Etanercept Market Restraints
Table 20. Global Etanercept Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global Etanercept Sales Share by Manufacturers (2017-2022)
Table 22. Global Etanercept Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Etanercept Manufacturers by Revenue (US$ Million) in 2021
Table 24. Etanercept Revenue Share by Manufacturers (2017-2022)
Table 25. Global Etanercept Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Etanercept as of 2021)
Table 27. Key Manufacturers Etanercept Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 28. Key Manufacturers Etanercept Plants/Factories Distribution
Table 29. Key Manufacturers Etanercept Area Served
Table 30. Date of Key Manufacturers Enter into Etanercept Market
Table 31. Key Manufacturers Etanercept Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Etanercept Sales (K Units) by Type (2017-2022)
Table 34. Global Etanercept Sales Share by Type (2017-2022)
Table 35. Global Etanercept Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Etanercept Price (K Units) by Type (2017-2022)
Table 37. Global Etanercept Sales (K Units) by Type (2023-2028)
Table 38. Global Etanercept Sales Share by Type (2023-2028)
Table 39. Global Etanercept Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Etanercept Revenue Share by Type (2023-2028)
Table 41. Global Etanercept Price (K Units) by Type (2023-2028)
Table 42. Global Etanercept Sales (K Units) by Application (2017-2022)
Table 43. Global Etanercept Sales Share by Application (2017-2022)
Table 44. Global Etanercept Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Etanercept Price (K Units) by Application (2017-2022)
Table 46. Global Etanercept Sales (K Units) by Application (2023-2028)
Table 47. Global Etanercept Sales Share by Application (2023-2028)
Table 48. Global Etanercept Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Etanercept Revenue Share by Application (2023-2028)
Table 50. Global Etanercept Price (K Units) by Application (2023-2028)
Table 51. North America Etanercept Sales by Company (2017-2022) & (K Units)
Table 52. North America Etanercept Sales Market Share by Company (2017-2022)
Table 53. North America Etanercept Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Etanercept Revenue Market Share by Company (2017-2022)
Table 55. North America Etanercept Sales by Type (2017-2022) & (K Units)
Table 56. North America Etanercept Sales by Type (2023-2028) & (K Units)
Table 57. North America Etanercept Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Etanercept Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Etanercept Sales by Application (2017-2022) & (K Units)
Table 60. North America Etanercept Sales by Application (2023-2028) & (K Units)
Table 61. North America Etanercept Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Etanercept Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Etanercept Sales by Country (2017-2022) & (K Units)
Table 64. North America Etanercept Sales by Country (2023-2028) & (K Units)
Table 65. North America Etanercept Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Etanercept Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Etanercept Sales by Company (2017-2022) & (K Units)
Table 68. Europe Etanercept Sales Market Share by Company (2017-2022)
Table 69. Europe Etanercept Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Etanercept Revenue Market Share by Company (2017-2022)
Table 71. Europe Etanercept Sales by Type (2017-2022) & (K Units)
Table 72. Europe Etanercept Sales by Type (2023-2028) & (K Units)
Table 73. Europe Etanercept Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Etanercept Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Etanercept Sales by Application (2017-2022) & (K Units)
Table 76. Europe Etanercept Sales by Application (2023-2028) & (K Units)
Table 77. Europe Etanercept Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Etanercept Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Etanercept Sales by Country (2017-2022) & (K Units)
Table 80. Europe Etanercept Sales by Country (2023-2028) & (K Units)
Table 81. Europe Etanercept Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Etanercept Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Etanercept Sales by Company (2017-2022) & (K Units)
Table 84. Asia Pacific Etanercept Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Etanercept Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Etanercept Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Etanercept Sales by Type (2017-2022) & (K Units)
Table 88. Asia Pacific Etanercept Sales by Type (2023-2028) & (K Units)
Table 89. Asia Pacific Etanercept Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Etanercept Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Etanercept Sales by Application (2017-2022) & (K Units)
Table 92. Asia Pacific Etanercept Sales by Application (2023-2028) & (K Units)
Table 93. Asia Pacific Etanercept Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Etanercept Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Etanercept Sales by Region (2017-2022) & (K Units)
Table 96. Asia Pacific Etanercept Sales by Region (2023-2028) & (K Units)
Table 97. Asia Pacific Etanercept Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Etanercept Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Etanercept Sales by Company (2017-2022) & (K Units)
Table 100. Latin America Etanercept Sales Market Share by Company (2017-2022)
Table 101. Latin America Etanercept Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Etanercept Revenue Market Share by Company (2017-2022)
Table 103. Latin America Etanercept Sales by Type (2017-2022) & (K Units)
Table 104. Latin America Etanercept Sales by Type (2023-2028) & (K Units)
Table 105. Latin America Etanercept Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Etanercept Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Etanercept Sales by Application (2017-2022) & (K Units)
Table 108. Latin America Etanercept Sales by Application (2023-2028) & (K Units)
Table 109. Latin America Etanercept Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Etanercept Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Etanercept Sales by Country (2017-2022) & (K Units)
Table 112. Latin America Etanercept Sales by Country (2023-2028) & (K Units)
Table 113. Latin America Etanercept Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Etanercept Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Etanercept Sales by Company (2017-2022) & (K Units)
Table 116. Middle East and Africa Etanercept Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Etanercept Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Etanercept Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Etanercept Sales by Type (2017-2022) & (K Units)
Table 120. Middle East and Africa Etanercept Sales by Type (2023-2028) & (K Units)
Table 121. Middle East and Africa Etanercept Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Etanercept Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Etanercept Sales by Application (2017-2022) & (K Units)
Table 124. Middle East and Africa Etanercept Sales by Application (2023-2028) & (K Units)
Table 125. Middle East and Africa Etanercept Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Etanercept Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Etanercept Sales by Country (2017-2022) & (K Units)
Table 128. Middle East and Africa Etanercept Sales by Country (2023-2028) & (K Units)
Table 129. Middle East and Africa Etanercept Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Etanercept Revenue by Country (2023-2028) & (US$ Million)
Table 131. Amgen Corporation Information
Table 132. Amgen Description and Overview
Table 133. Amgen Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 134. Amgen Etanercept Product and Services
Table 135. Amgen Etanercept SWOT Analysis
Table 136. Amgen Recent Developments
Table 137. Pfizer Corporation Information
Table 138. Pfizer Description and Overview
Table 139. Pfizer Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 140. Pfizer Etanercept Product and Services
Table 141. Pfizer Etanercept SWOT Analysis
Table 142. Pfizer Recent Developments
Table 143. Takeda Corporation Information
Table 144. Takeda Description and Overview
Table 145. Takeda Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 146. Takeda Etanercept Product and Services
Table 147. Takeda Etanercept SWOT Analysis
Table 148. Takeda Recent Developments
Table 149. Sanofi Corporation Information
Table 150. Sanofi Description and Overview
Table 151. Sanofi Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 152. Sanofi Etanercept Product and Services
Table 153. Sanofi Etanercept SWOT Analysis
Table 154. Sanofi Recent Developments
Table 155. GlaxoSmithKline Corporation Information
Table 156. GlaxoSmithKline Description and Overview
Table 157. GlaxoSmithKline Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 158. GlaxoSmithKline Etanercept Product and Services
Table 159. GlaxoSmithKline Etanercept SWOT Analysis
Table 160. GlaxoSmithKline Recent Developments
Table 161. Sandoz Corporation Information
Table 162. Sandoz Description and Overview
Table 163. Sandoz Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 164. Sandoz Etanercept Product and Services
Table 165. Sandoz Etanercept SWOT Analysis
Table 166. Sandoz Recent Developments
Table 167. Celltrion Corporation Information
Table 168. Celltrion Description and Overview
Table 169. Celltrion Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 170. Celltrion Etanercept Product and Services
Table 171. Celltrion Etanercept SWOT Analysis
Table 172. Celltrion Recent Developments
Table 173. Dexa Medica Corporation Information
Table 174. Dexa Medica Description and Overview
Table 175. Dexa Medica Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 176. Dexa Medica Etanercept Product and Services
Table 177. Dexa Medica Etanercept SWOT Analysis
Table 178. Dexa Medica Recent Developments
Table 179. Bionovis Corporation Information
Table 180. Bionovis Description and Overview
Table 181. Bionovis Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 182. Bionovis Etanercept Product and Services
Table 183. Bionovis Etanercept SWOT Analysis
Table 184. Bionovis Recent Developments
Table 185. Momenta Pharmaceuticals Corporation Information
Table 186. Momenta Pharmaceuticals Description and Overview
Table 187. Momenta Pharmaceuticals Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 188. Momenta Pharmaceuticals Etanercept Product and Services
Table 189. Momenta Pharmaceuticals Etanercept SWOT Analysis
Table 190. Momenta Pharmaceuticals Recent Developments
Table 191. HanAll Biopharma Corporation Information
Table 192. HanAll Biopharma Description and Overview
Table 193. HanAll Biopharma Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 194. HanAll Biopharma Etanercept Product and Services
Table 195. HanAll Biopharma Recent Developments
Table 196. MedImmune Corporation Information
Table 197. MedImmune Description and Overview
Table 198. MedImmune Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 199. MedImmune Etanercept Product and Services
Table 200. MedImmune Recent Developments
Table 201. Tsumura Corporation Information
Table 202. Tsumura Description and Overview
Table 203. Tsumura Etanercept Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 204. Tsumura Etanercept Product and Services
Table 205. Tsumura Recent Developments
Table 206. Key Raw Materials Lists
Table 207. Raw Materials Key Suppliers Lists
Table 208. Etanercept Distributors List
Table 209. Etanercept Customers List
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Etanercept Product Picture
Figure 2. Global Etanercept Sales Market Share by Type in 2021 & 2028
Figure 3. Benepali Product Picture
Figure 4. Enbrel Product Picture
Figure 5. Others Product Picture
Figure 6. Global Etanercept Sales Market Share by Application in 2021 & 2028
Figure 7. Arthritis Use Case
Figure 8. Psoriasis Use Case
Figure 9. Spondylitis Use Case
Figure 10. Others Use Case
Figure 11. Etanercept Report Years Considered
Figure 12. Global Etanercept Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Etanercept Market Size 2017-2028 (US$ Million)
Figure 14. Global Etanercept Sales (2017-2022) & (K Units)
Figure 15. Global Etanercept Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Etanercept Sales Market Share by Region (2017-2022)
Figure 17. Global Etanercept Sales Market Share by Region in 2021
Figure 18. Global Etanercept Revenue Market Share by Region in 2017 VS 2021
Figure 19. Global Etanercept Sales Share by Manufacturers in 2021
Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Etanercept Sales in 2021
Figure 21. Etanercept Revenue Share by Manufacturers in 2021
Figure 22. Etanercept Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 23. Global Etanercept Revenue Share by Type (2017-2022)
Figure 24. Global Etanercept Revenue Growth Rate by Type in 2017 & 2021
Figure 25. Global Etanercept Revenue Share by Application (2017-2022)
Figure 26. Global Etanercept Revenue Growth Rate by Application in 2017 & 2021
Figure 27. North America Etanercept Sales Market Share by Type (2017-2028)
Figure 28. North America Etanercept Revenue Market Share by Type (2017-2028)
Figure 29. North America Etanercept Sales Market Share by Application (2017-2028)
Figure 30. North America Etanercept Revenue Market Share by Application (2017-2028)
Figure 31. North America Etanercept Sales Share by Country (2017-2028)
Figure 32. North America Etanercept Revenue Share by Country (2017-2028)
Figure 33. U.S. Etanercept Revenue (2017-2028) & (US$ Million)
Figure 34. Canada Etanercept Revenue (2017-2028) & (US$ Million)
Figure 35. Europe Etanercept Sales Market Share by Type (2017-2028)
Figure 36. Europe Etanercept Revenue Market Share by Type (2017-2028)
Figure 37. Europe Etanercept Sales Market Share by Application (2017-2028)
Figure 38. Europe Etanercept Revenue Market Share by Application (2017-2028)
Figure 39. Europe Etanercept Sales Share by Country (2017-2028)
Figure 40. Europe Etanercept Revenue Share by Country (2017-2028)
Figure 41. Germany Etanercept Revenue (2017-2028) & (US$ Million)
Figure 42. France Etanercept Revenue (2017-2028) & (US$ Million)
Figure 43. U.K. Etanercept Revenue (2017-2028) & (US$ Million)
Figure 44.
Write comment about above report:
Related Reports
|
Global Adalimumab, Infliximab And Etanercept Biosimilars Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Biosimilar is a biologic medical product which is highly similar to another already approved biological medicine. Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name ... |
|
Global Etanercept Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by acting as a TNF inhibitor. Report Ove... |
We are on:
Why ReportsnReports.com?
- 500,000 market research reports and growing.
- Top Fortune 500 Organizations trust us for research data.
- 24/7 support on call as well as emails.
- Your Details are safe with us.
- Free support for your research requirements.
- Report Delivery: Email
- Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays